The Board of Directors of Guangzhou Wondfo Biotech Co.,Ltd has authorized a buyback plan on July 5, 2023.
Guangzhou Wondfo Biotech Co.,Ltd
Equities
300482
CNE100002102
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.9 CNY | +0.10% | -2.56% | -4.21% |
May. 06 | Wondfo Biotech's Unit Gets Emergency Use Authorization from US FDA | MT |
Apr. 21 | Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.21% | 1.87B | |
-6.26% | 12.23B | |
-3.93% | 8.17B | |
+7.10% | 5.78B | |
+30.16% | 5.74B | |
-7.47% | 4.24B | |
-57.20% | 2.97B | |
+12.56% | 2.73B | |
-4.67% | 2.38B | |
+27.38% | 2.26B |
- Stock Market
- Equities
- 300482 Stock
- News Guangzhou Wondfo Biotech Co.,Ltd
- Guangzhou Wondfo Biotech Co.,Ltd authorizes a Buyback Plan.